Human CD133-positive hematopoietic progenitor cells enhance the malignancy of breast cancer cells

BACKGROUND: Human CD133+ hematopoietic progenitor cells (HPCs) are a specific subset of cells that can regulate tumor malignancy. However, the mechanism by which CD133+ HPCs affect the malignancy of human breast cancer has not been reported. METHODS: CD133+ HPCs were isolated and purified from human...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Zhang, Zhe, Zheng, Qinglian, Liu, Yonghui, Sun, Lianqing, Han, Pingping, Wang, Rui, Zhao, Jiao, Hu, Shan, Zhao, Xinhan
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7690192/
https://ncbi.nlm.nih.gov/pubmed/33243165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07633-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars